ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Cabaletta Bio at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
Cabaletta Bio brings 3 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 4104. Its program centres on rese-cel, an engineered CAR T-cell therapy, covering its safety profile in refractory autoimmune disease, the RESET clinical program and a survey of preferences for CAR T-cell use in myositis.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
Cabaletta Bio Philadelphia, PA | |
A clinical-stage biotechnology company developing engineered T-cell therapies for autoimmune diseases. | Booth Exhibiting at Booth 4104 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Industry Tue Nov 10 1:30pm–2:15pm Designed for Autoimmunity: Rese-cel and the RESET Clinical Program |
Find decision makers at Cabaletta Bio
Tell us what you sell and we’ll find the people at Cabaletta Bio most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction